DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 888 filers reported holding DANAHER CORPORATION in Q3 2014. The put-call ratio across all filers is 0.41 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $12,066,006 | -1.2% | 48,293 | -1.2% | 1.32% | -3.0% |
Q1 2024 | $12,208,561 | +6.0% | 48,889 | -1.8% | 1.36% | -3.3% |
Q4 2023 | $11,518,881 | -7.2% | 49,792 | -0.4% | 1.41% | -15.9% |
Q3 2023 | $12,408,970 | +2.0% | 50,016 | -1.3% | 1.68% | +6.7% |
Q2 2023 | $12,167,040 | -6.2% | 50,696 | -1.5% | 1.57% | -7.0% |
Q1 2023 | $12,970,735 | +93053.8% | 51,463 | -1.9% | 1.69% | -10.1% |
Q4 2022 | $13,924 | -99.9% | 52,462 | -1.4% | 1.88% | -5.5% |
Q3 2022 | $13,745,000 | +1.9% | 53,216 | +0.0% | 1.99% | +8.3% |
Q2 2022 | $13,485,000 | -14.9% | 53,193 | -1.6% | 1.84% | +0.2% |
Q1 2022 | $15,855,000 | -10.6% | 54,052 | +0.2% | 1.84% | 0.0% |
Q4 2021 | $17,743,000 | +0.7% | 53,929 | -6.8% | 1.84% | -6.6% |
Q3 2021 | $17,611,000 | +9.9% | 57,848 | -3.2% | 1.97% | +12.1% |
Q2 2021 | $16,031,000 | +17.8% | 59,735 | -1.2% | 1.75% | +13.2% |
Q1 2021 | $13,606,000 | -0.3% | 60,447 | -1.6% | 1.55% | -3.4% |
Q4 2020 | $13,650,000 | +2.6% | 61,447 | -0.6% | 1.60% | -8.2% |
Q3 2020 | $13,310,000 | +18.2% | 61,813 | -2.9% | 1.75% | +9.4% |
Q2 2020 | $11,262,000 | +26.4% | 63,691 | -1.1% | 1.60% | +7.8% |
Q1 2020 | $8,911,000 | -10.3% | 64,378 | -0.5% | 1.48% | +16.7% |
Q4 2019 | $9,930,000 | +2.8% | 64,700 | -3.3% | 1.27% | -3.0% |
Q3 2019 | $9,659,000 | -1.6% | 66,876 | -2.6% | 1.31% | -3.3% |
Q2 2019 | $9,816,000 | +6.5% | 68,686 | -1.7% | 1.35% | +2.6% |
Q1 2019 | $9,221,000 | +24.8% | 69,842 | -2.5% | 1.32% | +10.5% |
Q4 2018 | $7,388,000 | -5.1% | 71,640 | -0.0% | 1.19% | +10.0% |
Q3 2018 | $7,788,000 | +8.8% | 71,672 | -1.1% | 1.08% | +4.9% |
Q2 2018 | $7,155,000 | -0.7% | 72,504 | -1.4% | 1.03% | -0.6% |
Q1 2018 | $7,202,000 | +8.6% | 73,557 | +3.0% | 1.04% | +14.0% |
Q4 2017 | $6,629,000 | +7.1% | 71,418 | -1.0% | 0.91% | +1.4% |
Q3 2017 | $6,187,000 | +1.1% | 72,128 | -0.6% | 0.90% | -0.8% |
Q2 2017 | $6,120,000 | -2.9% | 72,531 | -1.6% | 0.91% | -4.6% |
Q1 2017 | $6,303,000 | +11.4% | 73,697 | +1.4% | 0.95% | +14.9% |
Q4 2016 | $5,659,000 | +1.5% | 72,700 | +2.2% | 0.83% | +2.0% |
Q3 2016 | $5,574,000 | -19.7% | 71,103 | +3.5% | 0.81% | -20.3% |
Q2 2016 | $6,941,000 | +7.4% | 68,715 | +0.9% | 1.02% | +0.9% |
Q1 2016 | $6,461,000 | +7.4% | 68,115 | +5.2% | 1.01% | +4.6% |
Q4 2015 | $6,015,000 | +6.0% | 64,765 | -2.7% | 0.96% | -7.7% |
Q3 2015 | $5,672,000 | -4.2% | 66,566 | -3.8% | 1.04% | +5.4% |
Q2 2015 | $5,921,000 | -1.4% | 69,175 | -2.2% | 0.99% | -0.2% |
Q1 2015 | $6,006,000 | -1.4% | 70,750 | -0.4% | 0.99% | -2.8% |
Q4 2014 | $6,091,000 | +10.5% | 71,060 | -2.1% | 1.02% | +4.8% |
Q3 2014 | $5,513,000 | -7.3% | 72,565 | -3.9% | 0.98% | -5.0% |
Q2 2014 | $5,946,000 | -23.7% | 75,524 | -27.4% | 1.03% | -4.7% |
Q1 2014 | $7,798,000 | -3.3% | 103,985 | -0.5% | 1.08% | -4.6% |
Q4 2013 | $8,065,000 | +6.3% | 104,469 | -4.6% | 1.13% | -3.3% |
Q3 2013 | $7,588,000 | +7.2% | 109,463 | -2.1% | 1.17% | +30.8% |
Q2 2013 | $7,077,000 | – | 111,797 | – | 0.89% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
WALTER & KEENAN WEALTH MANAGEMENT LLC /IN/ /ADV | 263,188 | $33,896,000 | 13.46% |
ARTHUR M. COHEN & ASSOCIATES, LLC | 263,188 | $33,896,000 | 13.46% |
Defender Capital, LLC. | 127,230 | $17,610,000 | 12.86% |
Eos Focused Equity Management, L.P. | 53,908 | $7,461,000 | 11.12% |
CORTLAND ASSOCIATES INC/MO | 419,035 | $57,999,000 | 10.88% |
Mirova US LLC | 477,368 | $66,072,000 | 8.75% |
Pactiv General Employee Benefit Trust | 579,300 | $80,181,000 | 8.58% |
Riverstone Advisors, LLC | 57,623 | $7,976,000 | 8.07% |
Eversept Partners, LP | 233,957 | $32,419,197 | 8.06% |
Third Point | 3,570,000 | $494,124,000 | 7.88% |